TY - JOUR
T1 - Screening of hepatitis G and epstein-barr viruses among voluntary non remunerated blood donors (VNRBD) in burkina faso, west africa
AU - Tao, Issoufou
AU - Bisseye, Cyrille
AU - Nagalo, Bolni Marius
AU - Sanou, Mahamoudou
AU - Kiba, Alice
AU - Surat, Guzin
AU - Compaoré, Tegwindé Rebeca
AU - Traoré, Lassina
AU - Nikiema, Jean Baptiste
AU - Pietra, Virginio
AU - Zongo, Jean Didier
AU - Simpore, Jacques
PY - 2013
Y1 - 2013
N2 - In most sub-Saharan countries screening of blood-transmitted infections includes mainly HIV, HBV, HCV and syphilis. Many viruses such as Hepatitis G (HGV) and Epstein-Barr virus (EBV) which also carry a risk of transmission by blood transfusion raise the question of the extent of screening for these pathogens. This work aims to evaluate the prevalence of HGV and EBV in first-time blood donors in Ouagadougou. The prevalence of HGV and EBV in 551 blood donors was 7.4% and 5.4% respectively. HGV prevalence was significantly higher in blood donors with hepatitis B antigens and positive for HCV compared to donors negative for HCV and no hepatitis B antigens (respectively p<0.001 and p=0.004). EBV prevalence was higher among blood donors of < 20 years age group. HBV and HCV positive individuals are not eligible for blood donation. This study shows significant results with regard to the prevalence of HGV and EBV prevalence in blood donors in Burkina Faso and emphasizes the need for a general screening.
AB - In most sub-Saharan countries screening of blood-transmitted infections includes mainly HIV, HBV, HCV and syphilis. Many viruses such as Hepatitis G (HGV) and Epstein-Barr virus (EBV) which also carry a risk of transmission by blood transfusion raise the question of the extent of screening for these pathogens. This work aims to evaluate the prevalence of HGV and EBV in first-time blood donors in Ouagadougou. The prevalence of HGV and EBV in 551 blood donors was 7.4% and 5.4% respectively. HGV prevalence was significantly higher in blood donors with hepatitis B antigens and positive for HCV compared to donors negative for HCV and no hepatitis B antigens (respectively p<0.001 and p=0.004). EBV prevalence was higher among blood donors of < 20 years age group. HBV and HCV positive individuals are not eligible for blood donation. This study shows significant results with regard to the prevalence of HGV and EBV prevalence in blood donors in Burkina Faso and emphasizes the need for a general screening.
UR - http://www.scopus.com/inward/record.url?scp=84890527741&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84890527741&partnerID=8YFLogxK
U2 - 10.4084/MJHID.2013.053
DO - 10.4084/MJHID.2013.053
M3 - Article
AN - SCOPUS:84890527741
SN - 2035-3006
VL - 5
SP - 1
EP - 5
JO - Mediterranean Journal of Hematology and Infectious Diseases
JF - Mediterranean Journal of Hematology and Infectious Diseases
IS - 1
ER -